MAPT and tauopathy: These combined data therefore suggested that expression of mutant Tau.P301L, and the concomitant early stages of beginning tauopathy marked by increased phosphorylation of protein tau in the entorhinal cortex, specifically impairs the expression of the synaptic CAM Nectin-3 in the SLM of the hippocampus.